A global study led by Paresh Dandona, MD, PhD, found a majority
of patients with Type 1 diabetes who were treated with
dapagliflozin, a Type 2 diabetes medicine, had a significant
decline in their blood sugar levels.
What is an academic medical center and why does it matter to
Western New York? The UB Alumni Association sponsors a panel
discussion and keynote by James Marks, MD, executive vice president
at the Robert Wood Johnson Foundation and UB medical school
Researchers in the Department of Medicine have published a study
that identifies a new way to predict which patients may be at a
higher risk for heart failure after undergoing Transcatheter Aortic
Valve Implantation (TAVR).